title: Inhibition of human platelet phospholipase A2 by mono(2-ethylhexyl)phthalate.
abstract: There is evidence that the carcinogenic and teratogenic effects attributed to the plasticizer di(2-ethylhexyl)phthalate (DEHP) are due to its major metabolite mono(2-ethylhexyl)phthalate (MEHP). MEHP is also formed ex vivo by a plasma enzyme in blood products stored in polyvinyl chloride (PVC) DEHP plastic containers. People who receive large amounts of blood products, such as hemophiliacs or patients undergoing hemodialysis, cardiopulmonary bypass, or massive transfusion, are exposed to significant levels of plasticizer. In this study, the platelet was used to show that MEHP inhibits phospholipase A2 (PLA2), one of enzymes important in the release of arachidonic acid from membrane phospholipids. Arachidonate is the parent molecule for the synthesis of prostaglandins, thromboxanes, leukotrienes, and lipoxins that are made by a wide variety of cells. PLA2 was measured by the liberation of 14C-arachidonic acid from 1-stearoyl-2-[1-14C]arachidonyl-L-3-phosphatidylcholine. MEHP inhibits PLA2 activity noncompetitively in intact human platelets and lysates with a Ki of 3.7 x 10(-4) M. DEHP does not inhibit PLA2 in whole platelets. Inhibition of PLA2 by MEHP occurs at only three times the circulating level of MEHP measured in neonates undergoing exchange transfusion and 20-fold the levels experienced by patients during cardiopulmonary bypass. Therefore, infants and adult patients with multisystem failure who accumulate MEHP in their blood may be at risk for decreased platelet function.
authors.affiliation: Ottawa Centre, Canadian Red Cross, Blood Transfusion Service, Ontario, Canada.
authors.forename: R S
authors.initials: RS
authors.lastname: Labow
authors.forename: E
authors.initials: E
authors.lastname: Meek
authors.forename: G A
authors.initials: GA
authors.lastname: Adams
authors.forename: G
authors.initials: G
authors.lastname: Rock
mesh_terms: D001792:Blood Platelets / Q000201:enzymology*; D004051:Diethylhexyl Phthalate / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D010795:Phthalic Acids / Q000494:pharmacology*
chemical_list: D010795:Phthalic Acids; D004051:Diethylhexyl Phthalate; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; C016599:mono-(2-ethylhexyl)phthalate